Subcutaneous versus intravenous administration of heparin in the treatment of deep vein thrombosis; which do patients prefer? A randomized cross-over study.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Postgraduate medical journal

• Publication date

  1992-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/pgmj.69.808.115PMID 8506190PMCID PMC2399638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subcutaneous Heparin Compared with Continuous Intravenous Heparin Administration in the Initial Treatment of Deep Vein Thrombosis

  1992cited by this paper
• Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.

  1987cited by this paper
• Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial.

  1987cited by this paper
• Subcutaneous administration of heparin. A randomised comparison with intravenous administration of heparin to patients with deep-vein thrombosis.

  1982cited by this paper
• An objective study of alternative methods of heparin administration.

  1980cited by this paper

• Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines.

  2020cites this paper
• BioAdvance Patient Support Program Survey: Positive Perception of Intravenous Infusions of Infliximab.

  2017cites this paper
• Role of Direct Oral Anticoagulants in the Management of Anticoagulation

  2017cites this paper
• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease

  2015cites this paper
• The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection

  2015cites this paper
• Intravenous versus Subcutaneous Drug Administration. Which Do Patients Prefer? A Systematic Review

  2015influential citation
• Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases

  2013cites this paper
• PENGARUH PEMBERIAN HEPARIN SUBKUTAN SEBAGAI PROFILAKSIS TROMBOSIS VENA DALAM (TVD) TERHADAP NILAI D-DIMER PADA PASIEN SAKIT KRITIS DI ICU RSUP DR. KARIADI

  2013cites this paper
• PERBANDINGAN PEMBERIAN HEPARIN SUBKUTAN DAN INTRAVENA TERHADAP KADAR FIBRINOGEN PADA PENCEGAHAN DEEP VEIN THROMBOSIS

  2012cites this paper
• Pengaruh Profilaksis Trombosis Vena Dalam dengan Heparin Subkutan dan Intravena terhadap aPTT dan Jumlah Trombosit pada Pasien Kritis di ICU RSUP Dr. Kariadi Semarang

  2012cites this paper
• Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)

  2011cites this paper
• Key References: Anticoagulation Monitoring

  2004cites this paper
• Hypercoagulability and the management of anticoagulant therapy in surgical patients: review and recommendations.

  1998cites this paper
• [Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: subjective and economic aspects].

  1998cites this paper
• College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.

  1998cites this paper
• The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.

  1996cites this paper
• Antithrombotic therapy for cerebrovascular disorders. An update.

  1995cites this paper